Olea sublingual allergoid immunotherapy administered with two different treatment regimens

Area of Science:

• Allergy and Immunology
• Immunotherapy Research
• Clinical Trials

Background:

• Sublingual immunotherapy (SLIT) is effective for allergies but requires long treatment durations.
• Standard SLIT regimens are less suitable for short-term allergies due to the time needed for clinical benefit.
• Alternative administration protocols are needed to expedite therapeutic effects.

Purpose of the Study:

• To compare a rapid, coseasonal SLIT protocol with a standard precoseasonal scheme.
• To determine if coseasonal SLIT can achieve similar benefits in a shorter timeframe.
• To evaluate the efficacy and safety of coseasonal SLIT for Olea allergy.

Main Methods:

• A prospective, randomized, drug-controlled study involving 33 patients with Olea allergy and rhinitis.
• Patients received either coseasonal SLIT (4-day build-up, 6 weeks), precoseasonal SLIT (10 weeks), or drug therapy.
• Symptom severity was assessed using a visual analog scale (VAS), and medication use was tracked via diaries.

Main Results:

• Coseasonal SLIT showed statistically significant VAS improvement compared to controls (p < 0.01).
• A significant reduction in rescue medication use was observed in the coseasonal SLIT group versus drug therapy (p < 0.05).
• One mild adverse event was reported, indicating a favorable safety profile.

Conclusions:

• Allergoid SLIT is effective and safe for Olea allergy.
• The coseasonal administration regimen provides rapid symptom relief and reduces medication needs.
• Coseasonal SLIT is a promising alternative for patients with short-lasting allergic conditions.